Insight Molecular Diagnostics OCX Stock
Insight Molecular Diagnostics Price Chart
Insight Molecular Diagnostics OCX Financial and Trading Overview
| Insight Molecular Diagnostics stock price | 3.2 USD |
| Previous Close | 0.22 USD |
| Open | 0.22 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 800 |
| Day's Range | 0.21 - 0.22 USD |
| 52 Week Range | 0.2 - 1.12 USD |
| Volume | 192.19K USD |
| Avg. Volume | 359.99K USD |
| Market Cap | 35.44M USD |
| Beta (5Y Monthly) | 1.58345 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.35 USD |
OCX Valuation Measures
| Enterprise Value | 31.94M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.34375 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 40.49887 |
| Price/Book (mrq) | 0.6761007 |
| Enterprise Value/Revenue | 36.5 |
| Enterprise Value/EBITDA | -1.394 |
Trading Information
Insight Molecular Diagnostics Stock Price History
| Beta (5Y Monthly) | 1.58345 |
| 52-Week Change | -77.72% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.12 USD |
| 52 Week Low | 0.2 USD |
| 50-Day Moving Average | 0.26 USD |
| 200-Day Moving Average | 0.45 USD |
OCX Share Statistics
| Avg. Volume (3 month) | 359.99K USD |
| Avg. Daily Volume (10-Days) | 241.95K USD |
| Shares Outstanding | 164.82M |
| Float | 88.65M |
| Short Ratio | 6.1 |
| % Held by Insiders | 7.86% |
| % Held by Institutions | 81.55% |
| Shares Short | 1.42M |
| Short % of Float | 1.60% |
| Short % of Shares Outstanding | 0.85% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3129.37% |
| Gross Margin | -18.85% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -14.94% |
| Return on Equity (ttm) | -18.40% |
Income Statement
| Revenue (ttm) | 875K USD |
| Revenue Per Share (ttm) | 0.007 USD |
| Quarterly Revenue Growth (yoy) | -21.80% |
| Gross Profit (ttm) | N/A |
| EBITDA | -22905000 USD |
| Net Income Avi to Common (ttm) | -10820000 USD |
| Diluted EPS (ttm) | -0.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 12.36M USD |
| Total Cash Per Share (mrq) | 0.08 USD |
| Total Debt (mrq) | 3.33M USD |
| Total Debt/Equity (mrq) | 7.65 USD |
| Current Ratio (mrq) | 1.659 |
| Book Value Per Share (mrq) | 0.318 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -41963000 USD |
| Levered Free Cash Flow (ttm) | -12704375 USD |
Profile of Insight Molecular Diagnostics
| Country | United States |
| State | CA |
| City | Irvine |
| Address | 15 Cushing |
| ZIP | 92618 |
| Phone | 949 409 7600 |
| Website | https://oncocyte.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 75 |
OncoCyte Corporation, a molecular diagnostics company, research, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, biopharma, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
Q&A For Insight Molecular Diagnostics Stock
What is a current OCX stock price?
Insight Molecular Diagnostics OCX stock price today per share is 3.2 USD.
How to purchase Insight Molecular Diagnostics stock?
You can buy OCX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Insight Molecular Diagnostics?
The stock symbol or ticker of Insight Molecular Diagnostics is OCX.
Which industry does the Insight Molecular Diagnostics company belong to?
The Insight Molecular Diagnostics industry is Diagnostics & Research.
How many shares does Insight Molecular Diagnostics have in circulation?
The max supply of Insight Molecular Diagnostics shares is 28.6M.
What is Insight Molecular Diagnostics Price to Earnings Ratio (PE Ratio)?
Insight Molecular Diagnostics PE Ratio is 0.00000000 now.
What was Insight Molecular Diagnostics earnings per share over the trailing 12 months (TTM)?
Insight Molecular Diagnostics EPS is 0 USD over the trailing 12 months.
Which sector does the Insight Molecular Diagnostics company belong to?
The Insight Molecular Diagnostics sector is Healthcare.
Insight Molecular Diagnostics OCX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 20418.46 USD — |
+0.03
|
7.76B USD — | 20377.36 USD — | 20480.89 USD — | — - | 7.76B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 2076.55 USD — |
+0.69
|
— — | 2067.9 USD — | 2081.27 USD — | — - | — — |
| NASDAQ DM Ind Goods & Svcs Lg M NQDM2700LMJPYT | 1761.11 JPY 11.89 USD |
<0.01
|
— — | 1761.11 JPY 11.89 USD | 1761.11 JPY 11.89 USD | — - | — — |
| NASDAQ Biotechnology NBI | 4323.3 USD — |
+0.85
|
— — | 4287.9 USD — | 4358.15 USD — | — - | — — |
| Nasdaq Health Care IXHC | 975.08 USD — |
+0.67
|
— — | 969.33 USD — | 981.49 USD — | — - | — — |
| NASDAQ DM Ind Goods & Svcs Lg M NQDM2700LMT | 1757.5 USD — |
<0.01
|
— — | 1752.33 USD — | 1774.66 USD — | — - | — — |
- {{ link.label }} {{link}}